Is Interstitial Glucose Higher Than Blood Glucose?

Interstitial glucose is generally lower than blood glucose, not higher. Glucose travels from the bloodstream into the surrounding tissue fluid through capillary walls, so the interstitial compartment is always playing catch-up with whatever the blood is doing. That said, the relationship between the two is more dynamic and complicated than a simple “one is always lower,” and continuous glucose monitors can sometimes display numbers that look higher than a fingerstick reading taken at the same moment. Understanding why requires looking at the physiology of glucose transport, the quirks of sensor technology, and the real-world situations that stretch the gap between these two measurements.

How Glucose Gets From Blood to Tissue

Every cell in your body needs glucose, but that glucose starts its journey in the bloodstream. To reach the cells, it has to cross capillary walls and enter the interstitial fluid, the thin layer of liquid that surrounds cells in tissues like fat, muscle, and skin. This transport happens primarily through diffusion and convection, driven by concentration differences between the blood and the tissue space.¹ Once glucose arrives in the interstitial fluid, nearby cells consume it for energy, which keeps the concentration in that compartment slightly below what you’d measure in the blood. Lymphatic drainage also carries some interstitial fluid away, further influencing local glucose levels.

Because of this one-way flow from blood to tissue, the interstitial compartment is downstream. Blood glucose is the source, and interstitial glucose is the echo. Under stable, steady-state conditions, the two values are closely correlated, linked by what researchers describe as a kinetic equilibrium.² But “correlated” does not mean “identical.” There is always a gradient in both time and magnitude between the two compartments, and that gradient becomes especially pronounced when glucose levels are changing quickly.

The Five-to-Ten-Minute Delay

The most well-documented difference between blood and interstitial glucose is a time lag. When you eat a meal and your blood sugar begins to climb, the interstitial fluid doesn’t register that rise immediately. In healthy adults under fasting conditions, researchers have directly measured the physiological delay of glucose transport from the bloodstream to the subcutaneous interstitial space at roughly five to six minutes.³ Under more dynamic conditions, the observed lag tends to stretch further. One study using subcutaneous glucose sensors found time differences between blood and interstitial glucose ranging from four to ten minutes, with the interstitial reading trailing behind the blood reading in about 81% of paired measurements.⁴

This lag has a practical consequence that trips people up. When blood glucose is rising quickly after a meal, a continuous glucose monitor will underestimate the actual blood level because it hasn’t caught up yet. Conversely, when blood glucose is falling, the CGM reading will overestimate blood glucose for the same reason. The interstitial signal trails behind in both directions. So the question “is interstitial glucose higher or lower?” depends heavily on which direction glucose happens to be moving at any given moment. During a rapid drop, the CGM will display a number that appears higher than a simultaneous fingerstick. During a rapid rise, the CGM will show a number that looks lower.

Part of this lag is purely physiological, but CGM devices add their own delay on top. The sensor has to detect the glucose, process the electrochemical signal, and run it through an algorithm. In-vitro testing of CGM systems has found intrinsic device lag times ranging from about eight to forty minutes, depending on the system and the rate of glucose change.⁵ The faster glucose is rising or falling, the larger the mismatch between the CGM reading and the actual glucose concentration. Modern devices use predictive algorithms to partially compensate for this lag, but they cannot eliminate it entirely.⁶

Tissue Type Changes Everything

One detail that often gets lost in the “blood versus interstitial” conversation is that interstitial glucose concentration varies dramatically depending on which tissue you’re measuring. A study using ultraslow microdialysis in healthy volunteers found that fasting glucose in adipose (fat) tissue averaged only about 2.5 mmol/L, compared to roughly 4.7 mmol/L in blood. That is almost half. Yet in connective tissue, the fasting interstitial glucose was essentially identical to blood glucose, around 4.7 mmol/L, and the two tracked each other closely even after a glucose challenge.⁷

This matters because CGM sensors sit in the subcutaneous space, which is a mix of fat and connective tissue. Where exactly the sensor tip lands, how much adipose tissue is in that area, and how metabolically active the surrounding cells are all influence the glucose concentration the sensor actually sees. The difference between a sensor sitting in a pocket of connective tissue versus one surrounded by fat cells could be meaningful. It is one reason why two sensors placed on the same person at the same time can sometimes give noticeably different readings.

Sensor placement site also plays a role at a broader anatomical level. In a trial of the Dexcom G7, sensors worn on the upper arm had an overall mean absolute relative difference of about 8% compared to lab glucose, while sensors on the abdomen were slightly less accurate at about 9%.⁸ These are small differences, but they reflect the underlying variability in interstitial glucose depending on where you measure it.

When CGM Readings Appear Higher Than Fingersticks

If interstitial glucose is physiologically lower than blood glucose most of the time, why do some people see their CGM numbers sitting above their fingerstick readings? The answer often lies in how the device is calibrated and which device you’re using. CGM manufacturers apply proprietary algorithms that convert the raw interstitial signal into an estimated blood glucose value. These algorithms are designed to map interstitial readings onto blood glucose ranges so that the number on your screen is as close to a fingerstick as possible. But different manufacturers make different calibration choices, and those choices can shift the displayed number systematically higher or lower.

A case analysis comparing readings from a Dexcom G6, a Freestyle Libre, and a traditional glucometer illustrates this well. The Dexcom G6 consistently reported higher average glucose values than the glucometer, while the Freestyle Libre consistently reported lower values. The glucometer readings fell in between.⁹ So a person wearing a Dexcom might regularly see numbers that look higher than their fingerstick, while a person wearing a Libre might see the opposite. Neither is necessarily “wrong” in a dangerous sense, but the systematic offset can be confusing if you expect exact agreement.

This is worth emphasizing because many people who use CGMs notice a discrepancy and wonder which number to trust. In most cases, the difference reflects calibration philosophy and the inherent lag, not a fundamental error. When glucose is stable, the gap tends to narrow. When glucose is changing quickly, the gap widens regardless of which direction the device’s bias happens to lean.

Exercise and the Widening Gap

Physical activity is one of the situations where the difference between interstitial and blood glucose becomes most consequential. During exercise, blood flow shifts toward working muscles and away from the skin and subcutaneous tissue. This reduces glucose delivery to the interstitial space where the sensor sits, while simultaneously increasing glucose uptake by nearby muscle cells. The result is that the CGM reading can fall behind reality more than usual.

Research on adults with type 1 diabetes found that during prolonged aerobic exercise, the average lag time between CGM and blood glucose was about twelve minutes. During documented hypoglycemic episodes that occurred mid-exercise, the average blood glucose measured by fingerstick was around 60 mg/dL, while the CGM was still displaying roughly 81 mg/dL.¹⁰ That twenty-point gap could easily be the difference between feeling fine and experiencing symptoms of low blood sugar. For someone relying on their CGM to decide whether to eat a snack or adjust insulin, that overestimation is a real safety concern.

Beyond blood flow changes, exercise also alters interstitial fluid volume and the rate of fluid exchange between the bloodstream, tissue, and lymphatic system. All of these shifts make the interstitial compartment a less stable measurement environment during and immediately after physical activity.¹¹ The broader lesson is that CGM accuracy is not constant. It degrades precisely during the moments when accurate glucose data matters most.

Sleep Position and Compression Artifacts

A subtler version of the blood-flow problem happens at night. If you roll onto the arm or abdomen where your sensor is placed, the pressure can compress local tissue and reduce blood flow to the sensor area. This commonly causes sudden dips in the CGM reading that don’t correspond to actual drops in blood sugar. Occasionally, compressed tissue produces elevated readings instead.¹² These compression artifacts are a frequent source of false low alarms that wake CGM users in the middle of the night, and they are one of the more common complaints among people who use these devices long-term.

The underlying cause is the same as with exercise: anything that changes local blood perfusion to the sensor site will change the interstitial glucose reading, even though actual blood glucose hasn’t budged. This is a reminder that what a CGM measures is not a direct window into the bloodstream. It is a measurement of a specific tissue compartment, and that compartment is sensitive to local mechanical and circulatory conditions.

The Foreign Body Problem

When a CGM sensor is inserted under the skin, the body recognizes it as a foreign object and begins reacting to it. This inflammatory response, which includes local swelling, immune cell recruitment, and eventually scar-like tissue formation, can interfere with glucose diffusion to the sensor tip over time.¹³ In the early hours after insertion, the local trauma from the needle itself can suppress sensor response. Sensors implanted with larger-gauge needles showed lower initial performance compared to those inserted with smaller needles, though anti-inflammatory coatings helped counteract this effect.¹⁴

This is part of why most CGM manufacturers recommend a warm-up period after inserting a new sensor and warn that the first day’s readings may be less accurate. The tissue around the sensor tip is recovering from the insertion injury, and the local glucose environment doesn’t represent the broader interstitial space until things settle down. As the sensor ages, gradual encapsulation by fibrous tissue can also degrade accuracy, which is one reason sensors have a defined wear period before they must be replaced.

Medications That Fool the Sensor

Certain substances can cause CGM readings to spike without any actual change in blood glucose. The most well-known culprit is acetaminophen (paracetamol), which can be oxidized at the sensor electrode and generate an electrical signal that the device interprets as glucose. While most of the published evidence involves oral acetaminophen, intravenous administration can produce even more dramatic false elevations. A case report documented a rapid increase in CGM readings after intravenous acetaminophen was given to a child with type 1 diabetes, with no matching rise in blood glucose.¹⁵

Newer-generation sensors have improved their resistance to acetaminophen interference, but they are not completely immune. Other substances, including high-dose vitamin C and certain anesthetic agents, have also been reported to affect CGM accuracy. If you’re using a CGM and take any of these medications, checking the CGM reading against a fingerstick before making insulin dosing decisions is a reasonable precaution.

Why This Matters for Automated Insulin Delivery

The practical stakes of the blood-interstitial glucose gap have escalated as more people use automated insulin delivery systems. These systems, sometimes called artificial pancreas or closed-loop systems, use CGM data to automatically adjust insulin delivery in real time. If the CGM consistently overestimates blood glucose during a rapid fall, the algorithm may not reduce insulin delivery quickly enough, potentially allowing blood sugar to drop dangerously low. If the CGM underestimates during a rapid rise, the algorithm may not deliver enough insulin to keep post-meal spikes in check.

Researchers have pointed out that during periods of rapid glucose change, such as after meals, during exercise, or after insulin doses, the time lag can lead to misinterpretation of glucose trends and delayed therapy adjustments.¹⁶ Algorithms try to anticipate where glucose is heading using trend data, but they are working with inherently delayed information. A CGM-based system that thinks glucose is at 90 mg/dL and stable might actually be looking at a blood glucose of 75 mg/dL and falling fast. The consequences of that blind spot for insulin-dependent users are not trivial.¹⁷

Dermal Sensing and What Might Come Next

One area of active development is dermal glucose sensing, which targets the dermis rather than the deeper subcutaneous fat layer. The dermis has a denser capillary network and a different tissue composition, which could in principle reduce the time lag between blood and interstitial glucose. Early research suggests that dermal sensing may indeed offer a shorter delay compared to traditional subcutaneous CGM placement.¹⁶ If confirmed in larger studies, this approach could help close the accuracy gap during the high-stakes moments when glucose is changing rapidly.

Other research groups are exploring wearable optical sensors that measure glucose through the skin without breaking it, as well as implantable sensors with anti-inflammatory coatings designed to resist the foreign body response for months rather than days. None of these technologies have fully solved the fundamental challenge that interstitial glucose is not blood glucose, but they are chipping away at the lag and the variability that make current CGM readings imperfect. For the millions of people who rely on these devices daily, even shaving a few minutes off the lag time or reducing compression artifacts during sleep would represent a meaningful quality-of-life improvement.

Glucose Monitoring in Animals

The blood-interstitial glucose relationship is not unique to humans, and veterinary researchers have explored CGM technology in companion animals. In cats, the lag appears to be at least as problematic. One study using a flash glucose monitoring system in cats found that during rapid blood glucose increases (after an intravenous glucose bolus), interstitial glucose rose slowly and fell dramatically behind, with differences as large as 579 mg/dL during the initial thirty-minute window.¹⁸ That extreme divergence occurred under experimental conditions designed to push glucose up very fast, so it doesn’t represent typical day-to-day use, but it illustrates how fragile the blood-interstitial correlation becomes when glucose levels change rapidly. Veterinarians managing diabetic cats and dogs with CGMs face the same interpretive challenges as human clinicians, amplified by smaller body sizes and the difficulty of keeping sensors in place on animals that groom and scratch.